Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nobukazu Fujimoto

Showing results (41-50 of 108) with videos related to

Pageof 11
Sort By:
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|January 7, 2010
Tuberculosis diagnosed by PCR analysis of synovial fluidNobukazu Fujimoto, Kenichi Gemba, Atsushi Yao, et al.
BMC Cancer|April 27, 2019
Physician requests by patients with malignant pleural mesothelioma in JapanYasuko Nagamatsu, Isao Oze, Keisuke Aoe, et al.
Respiratory Medicine Case Reports|January 9, 2016
Lymphoproliferative disorder in pleural effusion in a subject with past asbestos exposureNaofumi Hara, Nobukazu Fujimoto, Yosuke Miyamoto, et al.
Acta Medica Okayama|March 5, 2010
Triplet chemotherapy with cisplatin, docetaxel, and irinotecan for patients with recurrent or refractory non-small cell lung cancerNobukazu Fujimoto, Katsuyuki Kiura, Nagio Takigawa, et al.
European Journal of Radiology|March 25, 2018
Low-dose chest computed tomography screening of subjects exposed to asbestosKatsuya Kato, Kenichi Gemba, Kazuto Ashizawa, et al.
BMC Cancer|March 29, 2018
Quality of life of survivors of malignant pleural mesothelioma in Japan: a cross sectional studyYasuko Nagamatsu, Isao Oze, Keisuke Aoe, et al.
Journal for Immunotherapy of Cancer|October 29, 2021
JME-001 phase II trial of first-line combination chemotherapy with cisplatin, pemetrexed, and nivolumab for unresectable malignant pleural mesotheliomaYosuke Miyamoto, Toshiyuki Kozuki, Keisuke Aoe, et al.
Oncology Reports|November 7, 2012
CD9 expression as a favorable prognostic marker for patients with malignant mesotheliomaVishwa Jeet Amatya, Yukio Takeshima, Keisuke Aoe, et al.
Case Reports in Oncology|September 5, 2017
Esophagobronchial Fistula in a Patient with Squamous Cell Carcinoma of the Lung: A Case ReportTaichi Ozeki, Michiko Asano, Nobukazu Fujimoto, et al.
Case Reports in Oncology|September 8, 2017
Adenocarcinoma of the Lung Acquiring Resistance to Afatinib by Transformation to Small Cell Carcinoma: A Case ReportJun Nishimura, Yosuke Miyamoto, Nobukazu Fujimoto, et al.
Pageof 11

Showing results (41-50 of 108) with videos related to

Sort By:
Pageof 11
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|January 7, 2010
Tuberculosis diagnosed by PCR analysis of synovial fluidNobukazu Fujimoto, Kenichi Gemba, Atsushi Yao, et al.
BMC Cancer|April 27, 2019
Physician requests by patients with malignant pleural mesothelioma in JapanYasuko Nagamatsu, Isao Oze, Keisuke Aoe, et al.
Respiratory Medicine Case Reports|January 9, 2016
Lymphoproliferative disorder in pleural effusion in a subject with past asbestos exposureNaofumi Hara, Nobukazu Fujimoto, Yosuke Miyamoto, et al.
Acta Medica Okayama|March 5, 2010
Triplet chemotherapy with cisplatin, docetaxel, and irinotecan for patients with recurrent or refractory non-small cell lung cancerNobukazu Fujimoto, Katsuyuki Kiura, Nagio Takigawa, et al.
European Journal of Radiology|March 25, 2018
Low-dose chest computed tomography screening of subjects exposed to asbestosKatsuya Kato, Kenichi Gemba, Kazuto Ashizawa, et al.
BMC Cancer|March 29, 2018
Quality of life of survivors of malignant pleural mesothelioma in Japan: a cross sectional studyYasuko Nagamatsu, Isao Oze, Keisuke Aoe, et al.
Journal for Immunotherapy of Cancer|October 29, 2021
JME-001 phase II trial of first-line combination chemotherapy with cisplatin, pemetrexed, and nivolumab for unresectable malignant pleural mesotheliomaYosuke Miyamoto, Toshiyuki Kozuki, Keisuke Aoe, et al.
Oncology Reports|November 7, 2012
CD9 expression as a favorable prognostic marker for patients with malignant mesotheliomaVishwa Jeet Amatya, Yukio Takeshima, Keisuke Aoe, et al.
Case Reports in Oncology|September 5, 2017
Esophagobronchial Fistula in a Patient with Squamous Cell Carcinoma of the Lung: A Case ReportTaichi Ozeki, Michiko Asano, Nobukazu Fujimoto, et al.
Case Reports in Oncology|September 8, 2017
Adenocarcinoma of the Lung Acquiring Resistance to Afatinib by Transformation to Small Cell Carcinoma: A Case ReportJun Nishimura, Yosuke Miyamoto, Nobukazu Fujimoto, et al.
Pageof 11